| RS2522724685 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS2522726645 |
FLNA
|
Health Risk |
Likely pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522726871 |
FLNA
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2522726926 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522728586 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522731492 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS2522733678 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522733776 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2522735557 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Heterotopia, periventricular |
| RS2522737552 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2522737559 |
FLNA
|
Health Risk |
Likely pathogenic |
— |
| RS2522740030 |
FLNA
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2522740256 |
FLNA
|
Health Risk |
Likely pathogenic |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS2522740258 |
FLNA
|
Health Risk |
Likely pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522741003 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2522741040 |
FLNA
|
Health Risk |
Likely pathogenic |
— |
| RS2522741180 |
FLNA
|
Health Risk |
Likely pathogenic |
FG syndrome 2, FG syndrome 2 |
| RS2522742297 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2522745674 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522747844 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS2522747986 |
FLNA
|
Health Risk |
Likely pathogenic |
— |
| RS2522748423 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS2522748497 |
GNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS2522748603 |
GNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS2522749173 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2522750344 |
GNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS2522751007 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 42 |
| RS2522752773 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2522752902 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2522753214 |
RBMX
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Shashi type, Syndromic X-linked intellectual disability Shashi type |
| RS2522753919 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522753973 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522756775 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2522757689 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522760708 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522760720 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522761063 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2522761716 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522762140 |
RBMX
|
Health Risk |
Pathogenic |
Severe X-linked intellectual disability, Gustavson type |
| RS2522762487 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS2522763814 |
FLNA
|
Health Risk |
Likely pathogenic |
Frontometaphyseal dysplasia, Oto-palato-digital syndrome |
| RS2522764531 |
FLNA
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2522765267 |
FLNA
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2522765595 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS2522766989 |
KDM6A
|
Health Risk |
Pathogenic |
KDM6A-related disorder, KDM6A-related disorder |
| RS2522767271 |
RBMX
|
Health Risk |
Likely pathogenic |
Severe X-linked intellectual disability, Gustavson type |
| RS2522770771 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2522771333 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Needles syndrome, Heterotopia |
| RS2522771398 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522771411 |
FLNA
|
Health Risk |
Likely pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522771473 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522771731 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522771783 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522771786 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522771792 |
FLNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522771899 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522772830 |
C8B
|
Health Risk |
Pathogenic |
— |
| RS2522775487 |
CHKB
|
Health Risk |
Likely pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2522778329 |
CHKB
|
Health Risk |
Likely pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2522782154 |
KDM6A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2522783978 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2522784063 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2522785657 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2522787001 |
EMD
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2522787159 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522787619 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522787812 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522788283 |
EMD
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2522788352 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522788362 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522789000 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522789017 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, Thyroid cancer |
| RS2522789026 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522789883 |
CHKB
|
Health Risk |
Likely pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2522789891 |
EMD
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 1, X-linked |
| RS2522789929 |
EMD
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 1, X-linked |
| RS2522790106 |
EMD
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 1, X-linked |
| RS2522790318 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522790590 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522790624 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522790651 |
EMD
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 1, X-linked |
| RS2522790689 |
EMD
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy 1 |
| RS2522790701 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522790717 |
EMD
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS2522791777 |
DNAAF6
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2522795281 |
C8B
|
Health Risk |
Likely pathogenic |
— |
| RS2522795828 |
DNAAF6
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS2522797198 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522797252 |
SH2D1A
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522797441 |
SH2D1A
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to SH2D1A deficiency, X-linked lymphoproliferative disease due to SH2D1A deficiency |
| RS2522797763 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522798017 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522798223 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522798233 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522798359 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2522799460 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2522799594 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522799648 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522804871 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS2522805333 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |